GlassScriptPhysician profile
Alana Mae Williams
NPI 1124106323
$12,914.72
in general payments reported to CMS, 2019-2025
32 companies · $4,588 in 2025
The $4,588 reported for 2025 was more than what 91% of Urogynecology and Reconstructive Pelvic Surgery (Obstetrics & Gynecology) providers received nationally (typical 2025 total: $413).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $5,398 · 2020: $302 · 2021: $595 · 2022: $594 · 2023: $1,073 · 2024: $364 · 2025: $4,588.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $4,160 · Food and Beverage: $1,865.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $4,160.00 |
| Food and Beverage | $1,865.22 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $5,220.20 | 2019-2023 | Da Vinci Surgical System |
| Medtronic, INC. | $4,599.10 | 2021-2025 | Interstim, Altaviva |
| Axonics, INC. | $641.68 | 2021-2024 | Axonics |
| Abbvie INC. | $401.71 | 2019-2025 | |
| Merz North America, INC. | $316.32 | 2019-2023 | Xeomin |
| Astellas Pharma US INC | $301.46 | 2019-2025 | Veozah |
| Caldera Medical, INC | $148.61 | 2021-2022 | |
| Pfizer INC. | $141.05 | 2020-2024 | |
| 180 Medical, INC. | $128.55 | 2022-2023 | |
| Smith+Nephew, INC. | $89.36 | 2023 | Stravix, Grafix, Grafix Pl |
| Boston Scientific Corporation | $86.55 | 2022-2025 | Axonics |
| Hologic Sales and Service, LLC | $78.64 | 2020-2024 | Myosure Tissue Removal Device, Acessa Provu System, Novasure |
| Organon LLC | $75.40 | 2024-2025 | Nexplanon |
| Bayer Healthcare Pharmaceuticals INC. | $59.68 | 2019-2022 | |
| Allergan, INC. | $56.53 | 2021 |
Show all 32 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $55.74 | 2019-2020 | |
| Stryker Corporation | $54.80 | 2023 | Stryker |
| Biohaven Pharmaceutical Holding Company LTD. | $52.83 | 2022 | |
| Therapeuticsmd, INC. | $51.59 | 2020 | |
| Sumitomo Pharma America, INC. | $48.39 | 2023 | Myfembree |
| Exact Sciences Corporation | $37.91 | 2025 | The Cologuard Plus Collection Kit |
| Astellas Pharma Global Development | $33.10 | 2023 | Veozah |
| Roche Diagnostics Corporation | $32.97 | 2021 | |
| Calyxo, INC. | $31.53 | 2025 | Cvac Aspiration System |
| Coopersurgical, INC. | $30.02 | 2020-2022 | |
| Medtronic USA, INC. | $29.56 | 2019-2020 | |
| Convatec INC. | $23.58 | 2023 | |
| Amag Pharmaceuticals, INC. | $19.98 | 2019 | |
| Myovant Sciences INC. | $18.64 | 2021 | |
| Exeltis, USA INC. | $16.58 | 2025 | Slynd |
| Meditrina | $16.43 | 2025 | |
| Biohaven Pharmaceuticals, INC. | $16.23 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alana Williams listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.